Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.68 -0.37 (-1.42%)
Official Closing Price Updated: 7:00 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers? ↗
Pfizer is an innovative pharmaceutical giant that investors have given up on, which is an opportunity if you think long-term. 
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Healthcare Stocks Every Retiree Should Consider ↗
If you are trying to generate income in retirement, these three high-yield healthcare stocks could be the perfect fit for you. 
Via The Motley Fool
Topics Intellectual Property Retirement
News headline image
Got $5,000 to Invest in a Volatile Market? Here's Exactly Where I'd Put It. ↗
Look for names that tend to trade independently of the overall market, and don't be afraid to achieve some income growth. 
Via The Motley Fool
Topics Economy
Pfizer Inc. (NYSE:PFE) Tops Q1 2026 Estimates Amid Strong Non-COVID Growth ↗
Via Chartmill
What Are Horizontal Mergers and Acquisitions?
Via BusinesNews Wire
Topics Economy
News headline image
GoodRx (GDRX) Q1 2026 Earnings Call Transcript ↗
GoodRx (GDRX) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There. ↗
The competition is far behind. 
Via The Motley Fool
News headline image
Forget Eli Lilly: These 2 Stocks Have More Upside ↗
Eli Lilly has a lofty valuation thanks to its strong GLP-1 growth, but don't count out these two competitors. 
Via The Motley Fool
What's going on in today's session: S&P500 most active stocks ↗
Via Chartmill
News headline image
Zoetis (NYSE:ZTS) Misses Q1 CY2026 Revenue Estimates, Stock Drops 13%
Animal health company Zoetis (NYSE:ZTS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales only rose 1.9% year on year to $2.26 billion. The com... 
Via StockStory
News headline image
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue
Medication company Viatris (NASDAQ:VTRS) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 8.1% year on year to $3.52 bil... 
Via StockStory
Topics Artificial Intelligence
News headline image
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics ↗
Is Pfizer a yield trap? No way. 
Via The Motley Fool
Topics Artificial Intelligence Earnings Intellectual Property
News headline image
History Suggests These 3 Stocks Are Due for a Major Rebound ↗
Investors often move like lemmings in the short term, giving long-term investors an opportunity to buy great companies. 
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
Novavax (NVAX) Q1 2026 Earnings Transcript ↗
Novavax (NVAX) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars
Vaccine biotechnology company Novavax (NASDAQ:NVAX) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 79.1% year on year to $139.5 mill... 
Via StockStory
News headline image
PFE Q1 Deep Dive: Oncology, Obesity Pipeline, and Legal Milestones Shape Outlook
Global pharmaceutical company Pfizer (NYSE:PFE) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.4% year on year to $14.45 ... 
Via StockStory
Topics Intellectual Property
News headline image
Down as Much as 55% and Still Magnificent: 3 Dividend Stocks Worth Holding for a Lifetime ↗
Just because a dividend stock has suffered a significant stumble doesn't mean the setback is permanent. It doesn't even mean its dividend is in jeopardy. 
Via The Motley Fool
News headline image
Pfizer (PFE) Q1 2026 Earnings Transcript ↗
Pfizer (PFE) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗
Via Chartmill
News headline image
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View ↗
Pfizer beats Q1 estimates with revenue growth and strong pipeline progress, extends Vyndamax patent outlook, and backs 2026 guidance. 
Via Benzinga
Topics Intellectual Property
News headline image
Dow Jumps Over 300 Points; Tyson Foods Posts Upbeat Earnings ↗
US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower. 
Via Benzinga
Topics Earnings Stocks
News headline image
Why Pfizer's 'Mild' First-Quarter Report Likely Won't Satisfy Skeptics ↗
Pfizer delivered better-than-expected sales and profit. 
Via Investor's Business Daily
News headline image
Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q1 CY2026
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q1 CY2026, with sales up 5.4% year on year to $14.45 billion. On th... 
Via StockStory
News headline image
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance
From Pfizer Inc.
Via Business Wire
News headline image
Poets&Quants™ Names Best & Brightest MBAs of 2026
May 5, 2026 -- Annual feature celebrates graduating business students for campus impact and professional achievement 
Via 24-7 Press Release
News headline image
Pfizer, Pinterest And 3 Stocks To Watch Heading Into Tuesday ↗
US stock futures up, key stocks to watch today: Pfizer, Pinterest, PayPal, ON Semiconductor, AMD. Check out Benzinga Pro's premarket coverage. 
Via Benzinga
News headline image
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy ↗
Pfizer and Arvinas secure FDA approval for VEPPANU (vepdegestrant), a first-of-its-kind treatment for ESR1-mutated advanced breast cancer. 
Via Benzinga
News headline image
Eli Lilly Topples After Weight-Loss Patient Reports A Surprise Side Effect ↗
Eli Lilly stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure. 
Via Investor's Business Daily
News headline image
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings ↗
Pfizer to release Q3 earnings on May 5, with analysts expecting 72 cents/share and a revenue of $13.8 billion. Annual dividend yield at 6.53%. 
Via Benzinga
News headline image
Eli Lilly Just Announced Fantastic News for Shareholders ↗
Lilly's weight loss drugs have been delivering blockbuster revenue. 
Via The Motley Fool
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.